Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Thought Leadership
Latest Report
Obesity matters for drug developers
Close to 40% of the US adult population is now obese and the WHO and AMA define obesity as a disease. So it’s perhaps no surprise that Evaluate Pharma is forecasting sales by indication of $50bn in 2028 and CAGR between 2021 and 2028 at around 36%. The R&D pipeline is filling up as more and more companies try to grab a slice of this…
Report library
EP Vantage 2018 Preview
Report Highlights M&A activity expected to climb after slow 2017 – US tax reform a deciding factor for big deals Another big year predicted for venture financing…
Evaluate Forecasting Excellence: The Value of Outliers in Consensus Forecasting
Key Report Themes Upside/downside radio metrics that identify companies that could either outperform in the coming years or are at risk Companies that could follow a…
